AustraliaPharmaceutical companies Eli Lilly and Novo Nordisk are running advertisements in Australia that promote their weight loss drugs while complying with local laws that prohibit direct promotion of prescription medications. These ads focus on raising awareness about obesity as a chronic disease rather than explicitly naming the drugs. The campaigns encourage viewers to consult their doctors for treatment options, avoiding any mention of specific product names, which would be illegal under current regulations. Lilly's 'We Won't Weight' campaign includes emotional storytelling featuring individuals discussing their struggles with weight and the role of genetics in obesity. Novo Nordisk previously ran a similar campaign called 'Tried Everything?' highlighting the challenges of traditional diet and exercise approaches to weight loss.
Bias read (Center): The article presents both the actions of pharmaceutical companies and the regulatory environment in Australia without overtly favoring either side. It describes the marketing strategies used by the companies and explains the legal restrictions they must follow, providing balanced information without
